- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Haywood Brown on the Importance of Postpartum Follow-Up
Haywood Brown, MD, immediate past president of the American College of Obstetricians and Gynecology (ACOG), discusses the importance of postpartum follow up, and the reasoning behind ACOG's recently revised committee opinion.
Transcript
ACOG recently released a revised committee opinion that proposes a new paradigm for postpartum care. What is the reason for this change?
Well this is something I’ve thought about for over a decade now— how we can improve the outcomes of women through postpartum follow up. And we’ve been stuck in the 6 weeks paradigm since the beginning of time, it seems. But really, it’s about seeing women when they need to be seen.
It’s very difficult to screen for postpartum depression if you don’t do it early. It’s very difficult to counsel women on breast feeding continuation if you don’t do it early. But once pregnancy complications occur— whether they be having a preterm baby or preeclampsia– the whole postpartum follow up really changes. The idea behind having an early visit and a later visit is so that you can discuss reproductive life planning and long-term health risks during that time period, over that 12 weeks.
Our whole objective is to do a better job with education of the patients, but also with the providers on the importance of postpartum follow up, and also guiding the principles for long-term health. That’s really the reason for the change, and that’s the reason that we proposed this for one of our task forces.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
